Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 10 days 3 hours 22 mins 1 secs SAVE YOUR SEAT!

An interview with Scott Summerfield: Emerging technologies in the bioanalytical field

6 Dec 2017
General interest

For our Spotlight on emerging technologies, we spoke to Scott Summerfield, Worldwide Head of Bioanalysis at GSK (Brentford, UK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.

Back to our Spotlight – Emerging technologies: DMPK and bioanalysis of small molecules

 

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline
  • AAPS PharmSci 360 2025: what can conference attendees look forward to?

Related tags

emerging technologies interview video
Previous article Next article

Related articles

7 JAN 2020 NEWS
The ABCs of bioanalysis – best of 2019
8 OCT 2018 DRUG DEVELOPMENT
Ask the Experts: Naidong Weng
12 FEB 2020 CHROMATOGRAPHY
Developing novel stationary phases and capillary columns – an interview with Joseph Pesek
3 NOV 2017 AN AUTHOR'S PERSPECTIVE
An author’s perspective: Zheng Ouyang on miniature mass spectrometry
4 MAY 2020 JOURNAL ARTICLES
Perspectives on the draft ICH M10 guidance: an interview with John Kadavil
17 APR 2019 CONFERENCE REPORTS
WRIB 2019 conference report
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone